| Nociceptor-specific gene deletion reveals a major role for Nav1. 7 (PN1) in acute and inflammatory pain MA Nassar, LC Stirling, G Forlani, MD Baker, EA Matthews, AH Dickenson, ... Proceedings of the National Academy of Sciences 101 (34), 12706-12711, 2004 | 851 | 2004 |
| Nociceptor-specific gene deletion using heterozygous NaV1. 8-Cre recombinase mice CL Stirling, G Forlani, MD Baker, JN Wood, EA Matthews, AH Dickenson, ... Pain 113 (1), 27-36, 2005 | 281 | 2005 |
| Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model S Ricciardi, EM Boggio, S Grosso, G Lonetti, G Forlani, G Stefanelli, ... Human molecular genetics 20 (6), 1182-1196, 2011 | 249 | 2011 |
| Moderate alcohol use and health: a consensus document A Poli, F Marangoni, A Avogaro, G Barba, S Bellentani, M Bucci, ... Nutrition, Metabolism and Cardiovascular Diseases 23 (6), 487-504, 2013 | 209 | 2013 |
| Functional consequences of mutations in CDKL5, an X-linked gene involved in infantile spasms and mental retardation I Bertani, L Rusconi, F Bolognese, G Forlani, B Conca, L De Monte, ... Journal of Biological Chemistry 281 (42), 32048-32056, 2006 | 170 | 2006 |
| Mucosal immune response in BNT162b2 COVID-19 vaccine recipients L Azzi, D Dalla Gasperina, G Veronesi, M Shallak, G Ietto, D Iovino, A Baj, ... EBioMedicine 75, 2022 | 168 | 2022 |
| Modulation of extracellular signal-regulated kinases cascade by chronic Δ9-tetrahydrocannabinol treatment T Rubino, G Forlani, D Viganò, R Zippel, D Parolaro Molecular and Cellular Neuroscience 25 (3), 355-362, 2004 | 90 | 2004 |
| CIITA-driven MHC class II expressing tumor cells as antigen presenting cell performers: toward the construction of an optimal anti-tumor vaccine RS Accolla, E Ramia, A Tedeschi, G Forlani Frontiers in immunology 10, 1806, 2019 | 80 | 2019 |
| Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects T Rubino, G Forlani, D Vigano, R Zippel, D Parolaro Journal of neurochemistry 93 (4), 984-991, 2005 | 71 | 2005 |
| The MeCP2/YY1 interaction regulates ANT1 expression at 4q35: novel hints for Rett syndrome pathogenesis G Forlani, E Giarda, U Ala, F Di Cunto, M Salani, R Tupler, ... Human molecular genetics 19 (16), 3114-3123, 2010 | 63 | 2010 |
| Boosting the MHC class II-restricted tumor antigen presentation to CD4+ T helper cells: a critical issue for triggering protective immunity and re-orienting the tumor … RS Accolla, L Lombardo, R Abdallah, G Raval, G Forlani, G Tosi Frontiers in oncology 4, 32, 2014 | 56 | 2014 |
| Temperature effects on the presteady‐state and transport‐associated currents of GABA cotransporter rGAT1 F Binda, E Bossi, S Giovannardi, G Forlani, A Peres FEBS letters 512 (1-3), 303-307, 2002 | 49 | 2002 |
| Mutation K448E in the external loop 5 of rat GABA transporter rGAT1 induces pH sensitivity and alters substrate interactions G Forlani, E Bossi, R Ghirardelli, S Giovannardi, F Binda, L Bonadiman, ... The Journal of Physiology 536 (2), 479-494, 2001 | 44 | 2001 |
| Localization, quantification and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL GU Raval, C Bidoia, G Forlani, G Tosi, A Gessain, RS Accolla Retrovirology 12, 1-15, 2015 | 41 | 2015 |
| Major histocompatibility complex class II transactivator CIITA is a viral restriction factor that targets human T-cell lymphotropic virus type 1 Tax-1 function and inhibits … G Tosi, G Forlani, V Andresen, M Turci, U Bertazzoni, G Franchini, G Poli, ... Journal of virology 85 (20), 10719-10729, 2011 | 39 | 2011 |
| Cytoplasmic localization of HTLV-1 HBZ protein: a biomarker of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) M Baratella, G Forlani, GU Raval, A Tedeschi, O Gout, A Gessain, G Tosi, ... PLoS neglected tropical diseases 11 (1), e0005285, 2017 | 38 | 2017 |
| The major histocompatibility complex class II transactivator CIITA inhibits the persistent activation of NF-κB by the human T cell lymphotropic virus type 1 Tax-1 oncoprotein G Forlani, R Abdallah, RS Accolla, G Tosi Journal of Virology 90 (7), 3708-3721, 2016 | 38 | 2016 |
| HTLV-1 HBZ viral protein: a key player in HTLV-1 mediated diseases M Baratella, G Forlani, RS Accolla Frontiers in microbiology 8, 328550, 2017 | 37 | 2017 |
| Modulation of the inward rectifier potassium channel IRK1 by the Ras signaling pathway S Giovannardi, G Forlani, E Bossi, M Balestrini, R Tonini, E Sturani, ... Journal of Biological Chemistry 277 (14), 12158-12163, 2002 | 37 | 2002 |
| Phase I/II multicenter trial of a novel therapeutic cancer vaccine, HepaVac-101, for hepatocellular carcinoma MW Löffler, S Gori, F Izzo, A Mayer-Mokler, PA Ascierto, A Königsrainer, ... Clinical Cancer Research 28 (12), 2555-2566, 2022 | 32 | 2022 |
